S

Synthena AG

Oligonucleotide based therapeutics

Treatment of genetic neuromuscular diseases by using its tricyclo-DNA molecular technology
Founded: 2010

About

No detailed description available.

Products & Services

-

Use Cases & Case Studies

-

Partnerships & Collaborations

-

Awards & Recognition

-

Contact Information